Wayne State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wayne State University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Wayne State University: 163 sponsored US clinical trials, 22 recruiting.
Wayne State University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 115 completed. 13 of these trials are in Phase 3-4 (later-stage) and 30 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 4 trials.
Top-decile sponsor footprint
Wayne State University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
115 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 1 of 4
Peer-Delivered Behavioral Activation in a CCBHC
NCT07219394
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
NCT07123467
VR Stimulation of Exercise Response in Sedentary Humans
NCT07296991
Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder
NCT06740487
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
NCT06593496
Surgical Operating Room Enhancement Curriculum for Medical Students
NCT07006337
Family Intervention for Black Teens With Type 1 Diabetes
NCT06275412
Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
NCT06297499
Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth
NCT06242704
Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids
NCT06297278
Development of a Smoking Cessation Video Series
NCT06443294
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
NCT05006079
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
NCT05022459
Contingency Management for Recovery Oriented Activities at Recovery Houses
NCT05585203
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348
Functional Brain Mapping for Patients with Epilepsy
NCT05755919
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
NCT04458688
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
NCT04986683
Longitudinal Neuroimaging in Sturge-Weber Syndrome
NCT04517565
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
NCT04218422
Opioid/Benzodiazepine Polydrug Abuse
NCT03696017
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea
NCT03736382
An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers
NCT06054412
Rapid Adaptation to Prevent Drug Use
NCT05806840
An Intervention to Enhance Well-Being in Trauma Exposed New Mothers
NCT05474534
Bringing Exposure Therapy to Real-Life Context With Augmented Reality-Dogs (ARET)-Dogs
NCT05067491
Evaluating the InPen in Pediatric Type 1 Diabetes
NCT05515939
Linkage, Empowerment, and Access to Prevent Hypertension
NCT05061108
rTMS, Stress and Opioid Use Disorder
NCT04920864
NET Device for Treating Opioid Use Disorder
NCT04916600
TRAIN-BW: Backward Walking Training in Multiple Sclerosis
NCT04091464
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
NCT04231708
Increasing Law Enforcement Application of Automated External Defibrillators (AED)s for Cardiac Arrest
NCT07649616
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
NCT06222268
Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD
NCT06953388
Timing of Opioid Administration and Postoperative Respiratory Depression.
NCT07227389
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
NCT05684978
Warrior CARE: Cannabis Behavioral Health
NCT06381180
School-based Practices in Arts and Resilience for Kids
NCT06945497
Increasing Effectiveness of an Alcohol Use Reduction Exercise Using Self-Talk Videos
NCT06593483
Multi-Level Stigma Intervention for Mental Health Services
NCT06200012
Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and Care
NCT05925374
Heartache and Backache- An Online Intervention Addressing Emotional and Physical Pain
NCT05513274
Project 1: ACHIEVE- HTN
NCT05295758
Sleep Hygiene Intervention on Undergraduate Students' Sleep and Stress
NCT05933746
Emotional Awareness and Expression Therapy for Prediabetes
NCT05344196
Exercise and Endocannabinoids for Brain and Mental Health
NCT06808490
Improving Asthma Referrals Following Emergency Department Evaluation
NCT05072808
Preventing Substance Use Among Youth
NCT04752189
Interactive Alcohol Decision-Making Programs
NCT05398315
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 12 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Wayne State University pipeline
22 recruiting of 163 indexed (13% open); 115 completed (71%).
Phase mix: 13 late (III/IV) vs 30 early (I/II) (early-phase heavy).
Top condition: Hypertension (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wayne State University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Wayne State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Temple University · 163 trials · 13% recruiting
- Tufts University · 163 trials · 6% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- University of Michigan · 13% recruiting · 1,327 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Beth Israel Deaconess Medical Center · 14% recruiting · 488 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Wayne State University page
163 registered trials is a research-attention snapshot, not an endorsement of Wayne State University or any single study.
- 22 of Wayne State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Wayne State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wayne State University pipeline card: 163 registered trials from official public datasets.Report a data error.